Dunn, L. A., Fury, M. G., Xiao, H., Baxi, S. S., Sherman, E. J., Korte, S., . . . Pfister, D. G. (2017). A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Ann Oncol.
Citação norma ChicagoDunn, L. A., et al. "A Phase II Study of Temsirolimus Added to Low-dose Weekly Carboplatin and Paclitaxel for Patients With Recurrent And/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)." Ann Oncol 2017.
Deismireacht MLADunn, L. A., et al. "A Phase II Study of Temsirolimus Added to Low-dose Weekly Carboplatin and Paclitaxel for Patients With Recurrent And/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)." Ann Oncol 2017.